<DOC>
	<DOCNO>NCT00358527</DOCNO>
	<brief_summary>This study hope show relieve participant 's nasal symptoms seasonal allergy use mometasone furoate nasal spray , participant obtain good quality night-time sleep , turn , cause less daytime sleepiness he/she function productively day .</brief_summary>
	<brief_title>Mometasone Furoate Sleep Disturbances Subjects With Seasonal Allergic Rhinitis ( Study P04608 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Must &gt; =18 year age old , either sex , race . Clinically symptomatic Screening ( Day 7 4 ) Baseline ( Day 1 ) At Screening Visit , must complaint sleep disturbance symptomatic seasonal allergic rhinitis ( SAR ) must score 30 great Sleep Disturbance Sleep Scale ( item 1,3,7 8 ) At Baseline Visit , must complaint sleep disturbance daytime somnolence symptomatic SAR score 30 great Sleep Problems Index II ( SLP9 ) 30 great Daytime Somnolence Sleep Scale ( item 6 , 9 , 11 ) Must 2year longer history SAR occur season current study . Must skin test positive outdoor allergen common subject SAR prevalent time study , , tree , grass , weed , ragweed , mold . The skin test perform Screening do within 12 month prior Screening Visit Must free clinically significant disease would interfere study evaluation Women childbearing potential need use medically accept method birth control prior Screening study , provide documentation surgical sterilization . Women sexually active enrollment must consent use medically accept method birth control if/when become sexually active study participation . Female subject childbearing potential must negative urine pregnancy test time enrollment Baseline Visit . Women pregnant , intend become pregnant study , nurse Evidence nasal polyp , deviate septum , intranasal anatomical obstruction ( ) would interfere nasal airflow Acute chronic sinusitis treat antibiotic and/or topical oral nasal decongestant Acute respiratory infection within 2 week Screening Visit Diagnosis clinically relevant sleep problem unassociated allergy Complaints ( within 12 month Screening Visit healthcare provider ) difficulty sleep daytime sleepiness experience SAR symptom , continue complaint Snoring associate enlarged uvula upper airway pathology Had episodes snore associate gasp choking Awakened suddenly , 1 occasion month precede Screening Visit , gasp choke feeling Requires use oral appliance night bruxism ( teeth gnash ) temporomandibular joint problem Diagnosis asthma daytime nighttime asthma symptom control shortacting beta2 adrenoceptor agonists Dependence nasal , oral ocular decongestant , nasal topical antihistamine , nasal steroid . Currently undergo progressive course immunotherapy ( hyposensitization ) . Subjects regular maintenance schedule prior Screening Visit wish remain schedule study eligible study inclusion ; however , may receive hyposensitization treatment within 24 hour prior study visit Smokers exsmokers smoke within previous 6 month Concomitant medical problem may interfere participation study , eg , repeat migraine episode , uncontrolled convulsive disorder . Any following clinical condition : Active quiescent tuberculosis infection respiratory tract , untreated fungal , bacterial , systemic viral infection ocular herpes simplex . Subjects participate clinical study ( y ) . Subjects allergic sensitivity study drug excipients . Subjects nightshift worker standard `` asleep night/awake day '' cycle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>